On Friday, Ventyx Biosciences Inc (NASDAQ: VTYX) was 12.92% up from the session before settling in for the closing price of $7.74. A 52-week range for VTYX has been $0.78 – $10.55.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -87.13%. When this article was written, the company’s average yearly earnings per share was at 26.52%. With a float of $64.07 million, this company’s outstanding shares have now reached $71.34 million.
Ventyx Biosciences Inc (VTYX) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Ventyx Biosciences Inc stocks. The insider ownership of Ventyx Biosciences Inc is 10.21%, while institutional ownership is 62.17%. The most recent insider transaction that took place on Dec 18 ’25, was worth 365,461. In this transaction CEO AND PRESIDENT of this company sold 47,345 shares at a rate of $7.72, taking the stock ownership to the 2,372,863 shares. Before that another transaction happened on Dec 18 ’25, when Company’s CHIEF SCIENTIFIC OFFICER sold 12,675 for $7.72, making the entire transaction worth $97,840. This insider now owns 489,481 shares in total.
Ventyx Biosciences Inc (VTYX) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.41 earnings per share (EPS) during the time that was better than consensus figure (set at -0.55) by 0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.89% during the next five years compared to -87.13% drop over the previous five years of trading.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
You can see what Ventyx Biosciences Inc (VTYX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 17.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.50, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.69 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
The latest stats from [Ventyx Biosciences Inc, VTYX] show that its last 5-days average volume of 1.96 million was inferior to 2.1 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 32.41%.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 78.20%, which indicates a significant increase from 74.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.60 in the past 14 days, which was higher than the 0.46 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.77, while its 200-day Moving Average is $3.54. Now, the first resistance to watch is $9.18. This is followed by the second major resistance level at $9.62. The third major resistance level sits at $10.32. If the price goes on to break the first support level at $8.04, it is likely to go to the next support level at $7.34. Assuming the price breaks the second support level, the third support level stands at $6.90.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
There are 71,359K outstanding shares of the company, which has a market capitalization of 623.67 million. As of now, sales total 0 K while income totals -135,120 K. Its latest quarter income was 0 K while its last quarter net income were -22,830 K.
